Leadership

Pharm Exec explores the power of workplace aesthetic on the intangibles of culture, morale-and corporate mission-in a visit to one big Pharma's unique US headquarters.

Why the industry needs more women in senior management roles-and the three strategies to get there.

The key to success in the modern pharma era is engaging a workforce that's flexible enough to keep pace with evolving needs. That’s where contingent labor comes in, writes Rebecca Cenni.

Amid the release of our eighth list of Emerging Pharma Leaders, it's fitting to take a look at the trends and values that will determine true leadership in big Pharma in the years ahead.

Institutionalizing the teachable moment with GENiE, and new network focused on advancing the idea that for healthcare to change, the education of its leaders must change first.

William Looney speaks to Dr. Claudia Graeve, who leads the Healthcare Businesswomen's Association's sole international chapter in Europe, on improving the prospects for female managers in the region.

How pharma can finally put true meaning behind its juiced-up jargon and turn the bluster into reality, by Lundbeck's Timothy White.

The Jim Carrey film Liar Liar showed us the comic consequences of always telling the truth. What if people in business did the same? Mike Straw considers what the impact on pharma would be.

Rick Koonce outlines the critical coaching steps to help top managers realize their potential in an industry undergoing significant restructuring of both human and financial capital.

John Ansell assesses the wide range of pharma MBA courses currently available, from the five-day "mini MBA" to year-long programs of study.

Lessons to win in a shifting market dynamic

Establishing a well-defined training program is a crucial activity for any biopharmaceutical organization, writes Susan J. Schniepp.

Commercial teams as well as patients can benefit from managed access programs.

The findings from a new study into women on boards within the European life sciences industry shows there is still work to be done, but suggest a better gender balance is within reach. Nick Stephens reports.

Meet the rest of 2012's Emerging Pharma Leaders. Can these 15 global trend setters set the mark on their time in history?

Clayton Christensen, author of "The Innovator's Dilemma", offers to collaborate with pharma CEOs on solutions to the strategic impasse around flagging drug productivity.

Mark McClelland and Candida Chandorkar outline how organizations sector can improve their continuing professional development and effectiveness at work.

A recent global CEO report reveals that 51% of pharma CEOs think it has become more difficult to hire workers within the sector, outweighing the same problem in all other industries surveyed.

The economic and financial crisis rumbles on, but data from Pharmaceutical Technology's 2011 annual employment survey shows a positive outlook for 2012.

Pharm Exec celebrates its 30th birthday with a gathering of 30 of the industry's key influencers of the last three decades.

Pharm Exec interviews some of this year's emerging leaders to learn their strategies for success.

Much has been said about the need and imperative for life science companies to comply with the various laws and regulations that govern our industry. More recently, state-level marketing laws have proliferated, adding new rules of the road and resulting in thousands of hours and millions of dollars for training, tracking, reporting, consulting, analysis, and support systems.

What does it take to keep your employees on board? In the 1980s, employees looked for performance pay. In the 1990s, they wanted job security. Employees' needs have changed as society has, yet one thing has remained the same: Employees are always looking for something more out of their jobs. They want better quality of life at work.

When translating English materials into other languages, be careful of words that mean one thing in one dialect and something else in another dialect. Otherwise, you run the risk of referring to coaches as animal trainers.

Job candidates that evangelize a company are worth more than PR campaigns.

It is unethical for a retained search firm to fill one client's needs by poaching people from another client that entrusts the firm with its searches and secrets. Partnering-and sharing fees-might be the solution.

Institutions bring value to industry not only through shared coursework or customized training programs, but also through leveraging the intellectual property of institutional personnel for corporate problem solving.

World-class talent seeks its own level, so hiring companies should make sure that those involved in the interviewing process are strong employees who represent the company as leaders in their own rights.

For the third year in a row, Abbott Labs has made it into the top 10 companies judged by DiversityInc magazine to have the most diverse workforce. According to DiversityInc co-founder Luke Visconti, that makes Abbott, number five in the ranking, extraordinary. Merck is the only other pharma company to make the cut, but comes in at number 24, and is on a downturn-it was ranked 13 last year.

You can have a biotech company with a great technology base, but if it doesn't have a product in Phase II development, Wall Street won't reward the company by increasing the value of its stock price. When products are valued over technology, there is a higher premium for commercially-focused business leaders.